U.S. Water Utilities Stock News

Microvast Holdings recently strengthened its finance leadership, appointing Rodney Worthen as Chief Financial Officer and hiring former NextDecade executive Eric N. Garcia as Chief Accounting Officer, both effective in early January 2026. These appointments bring a blend of corporate finance, investor relations, and Big Four audit experience that could influence how Microvast manages reporting quality, capital allocation, and future expansion decisions. Next, we’ll examine how bringing in a...

Madison Square Garden Sports (MSGS) is back in focus after reporting Q1 Fiscal 2026 results that beat EPS expectations, while revenue missed forecasts, alongside an amended $425 million revolving credit facility for the Knicks. See our latest analysis for Madison Square Garden Sports. The latest earnings surprise and expanded Knicks credit facility have come alongside a strong price run, with a 30-day share price return of 17.55% and a 1-year total shareholder return of 33.46%. This points to...

In early January 2026, Globus Medical, Inc. issued updated guidance, forecasting fourth-quarter 2025 sales of approximately US$823.2 million and full-year 2025 sales of about US$2.94 billion, while also setting a full-year 2026 revenue range of US$3.18 billion to US$3.22 billion. This guidance points to management’s confidence in underlying demand for its musculoskeletal and enabling technology portfolio, offering investors fresh insight into how scale from recent acquisitions and innovation...

Mineralys Therapeutics (MLYS) is back in focus after reporting third quarter 2025 earnings that surpassed expectations, updating investors on lorundrostat’s path toward a New Drug Application and expanding its clinical program. See our latest analysis for Mineralys Therapeutics. The latest updates on lorundrostat and Q3 2025 results come after a mixed year in the market, with a 1 day share price return of 4.33% to US$32.74, a 90 day share price return decline of 25.86%, and a 1 year total...

On January 8, 2026, Hippocratic AI announced a collaboration with Huron Consulting Group to deploy generative AI healthcare agents that support care navigation, discharge follow-up, chronic condition outreach, and other patient engagement tasks within Huron-led transformation programs across more than 1,000 healthcare organizations. The partnership combines Hippocratic AI's large-scale, safety-focused agent platform with Huron's healthcare consulting expertise, potentially deepening Huron's...

VAALCO Energy (EGY) is drawing attention after reporting full year 2025 production and sales volumes around the midpoint and top of guidance, alongside encouraging drilling results at its Etame complex offshore Gabon. See our latest analysis for VAALCO Energy. The production and sales update lands after a strong run in the share price, with a 7 day share price return of 23.29% and a 30 day share price return of 31.20%. The 5 year total shareholder return of 136.12% points to momentum that has...

American Bitcoin’s new disclosure focus American Bitcoin (ABTC) is drawing fresh attention after highlighting more than 5,098 Bitcoin in reserves and rolling out a Bitcoin Yield Metric aimed at giving investors clearer insight into changes in its holdings. See our latest analysis for American Bitcoin. That renewed focus on its 5,098 Bitcoin reserves and the new Bitcoin Yield Metric comes after a tough period, with American Bitcoin’s share price return declining 67.78% over 90 days and 7.87%...

Origin Bancorp overview and recent performance Origin Bancorp (OBK) has attracted investor attention recently, with the share price around $40.44 and a mix of short term and longer term total returns that give a useful starting point for evaluating the stock. See our latest analysis for Origin Bancorp. While the latest 1-day share price return of 0.10% is relatively muted, the 90-day share price return of 19.40% and 1-year total shareholder return of 17.02% suggest momentum has been building...

Biohaven (BHVN) is back in focus after reporting early clinical experience from its MoDE and TRAP degrader platforms in IgA nephropathy and Graves' disease, along with a fresh pipeline update at a major healthcare conference. See our latest analysis for Biohaven. Biohaven's recent MoDE and TRAP degrader data, along with its high profile conference appearance, comes after a sharp rebound in momentum, with a 7 day share price return of 18.27% and a 30 day share price return of 21.11% from a...

Sila Realty Trust, Inc. recently completed the US$43.1 million acquisition of a fully leased inpatient rehabilitation facility in Oklahoma City, Oklahoma, which has been expanded to 58 beds and is operated under a long-term absolute-net lease with a corporate guaranty. This transaction reinforces Sila Realty Trust’s focus on healthcare real estate anchored by long-duration, necessity-based assets with strong occupancy and limited local competition, aiming to support consistent cash...

In January 2026, 10x Genomics and its partners, including Dana-Farber Cancer Institute, Brigham & Women’s Hospital, the Cancer Research Institute and CareDx, announced a series of collaborations to apply single-cell and spatial technologies across oncology, autoimmune disease, immuno-oncology and transplantation, alongside unaudited 2025 revenue of about US$642.8 million, or US$598.7 million excluding patent litigation settlements. These alliances, together with plans for a CLIA-certified...

Middleby: Recent Performance Snapshot Middleby (MIDD) has been trading quietly, with the share price last closing at US$148.53 and showing mixed returns, including a small move over the past month and a stronger gain across the past 3 months. See our latest analysis for Middleby. While Middleby’s 1-day share price return of 0.21% decline and 7-day share price return of 5.81% decline suggest some recent cooling, the 90-day share price return of 10.44% and 1-year total shareholder return of...

Several firms have recently downgraded Douglas Emmett (DEI), pointing to persistent weakness in occupancy and leasing momentum across its Los Angeles office portfolio, along with lower funds from operations estimates and a slower regional recovery. See our latest analysis for Douglas Emmett. The recent downgrades arrive after a difficult period for investors, with a 1 year total shareholder return of 32.94% decline and a 5 year total shareholder return of 50.07% decline. The latest US$11.12...

Ardent Health (ARDT) is back in focus after a series of securities class action lawsuits tied to disclosures on accounts receivable accounting, higher professional liability reserves, and alleged weaknesses in financial reporting controls. See our latest analysis for Ardent Health. At the latest share price of $8.60, Ardent Health has seen a 41.5% decline in its 90 day share price return and a 39.01% fall in 1 year total shareholder return. Recent lawsuits appear to be keeping pressure on...

What recent performance suggests about Biglari Holdings (BH.A) Recent trading in Biglari Holdings (BH.A) has drawn attention, with the stock showing double digit returns over the past week, month, and past 3 months, prompting investors to reassess what is driving sentiment. See our latest analysis for Biglari Holdings. At a share price of $2,378.72, Biglari Holdings has seen a rapid shift in sentiment, with a 30 day share price return of 35.78% and a 1 year total shareholder return of...

Earlier this week, Brown-Forman expanded the national availability of its highly sought-after Woodford Reserve Double Double Oaked Bourbon, while also celebrating Old Forester’s heritage with a new documentary and the return of its 1924, 10-year-old age-stated Whiskey Row bourbon. These launches highlight how Brown-Forman is leaning on premium, story-rich bourbons to deepen brand loyalty at a time of industry headwinds. We’ll now examine how the nationwide Double Double Oaked release could...

Peabody Energy recently announced that its President and CEO, Jim Grech, has been appointed Chair of the National Coal Council, a federal advisory body that offers policy recommendations on coal to the U.S. Secretary of Energy. This appointment gives Peabody a higher-profile voice in coal policy discussions, which may influence how investors view the company’s role within the broader energy landscape. Next, we’ll examine how Grech’s new policy role could influence Peabody’s existing...

In the past quarter, Clean Harbors reported revenues of US$1.55 billion, up 1.3% year on year but missing analyst expectations, and continued to highlight growth in its Technical Services and Safety-Kleen Environmental Services businesses while presenting at investor conferences hosted by Needham and CJS Securities in January 2026. An interesting angle for investors is that, despite growth in key segments, Clean Harbors delivered the weakest performance versus analyst estimates among the...

In recent days, multiple firms including Citigroup, CIBC, Bernstein, and J.P. Morgan have updated their views on Waste Connections ahead of its previously scheduled fourth-quarter 2025 earnings release and 2026 outlook call. This cluster of analyst updates underscores growing focus on how sector headwinds in recycling and pricing assumptions could influence Waste Connections’ upcoming guidance. Now we’ll examine how this recent wave of analyst reassessments ahead of earnings may affect...

Earlier this week, MSA Safety’s Board declared a first‑quarter 2026 dividend of US$0.53 per common share and US$0.5625 per preferred share, payable in March to shareholders of record on February 13, 2026. This announcement extends the company’s more than five‑decade record of uninterrupted dividends with over a decade of consecutive annual increases, underscoring its focus on consistent shareholder returns. Next, we’ll examine how MSA Safety’s continued dividend commitment influences its...

Visteon (VC) has been drawing investor attention after a recent stretch of mixed share performance, with the stock showing a 3.9% decline over the past day and a 6.2% decline over the past month. See our latest analysis for Visteon. At a share price of $93.69, Visteon’s recent 7 day and 90 day share price returns of 8.05% and 18.26% declines contrast with a 1 year total shareholder return of 12.06%. This suggests shorter term momentum has been fading while longer term holders have still come...

In recent days, HEICO reported past record profitability, broad-based revenue growth, and strong cash generation, underpinned by resilient aviation support demand and continued acquisitions. This combination of robust operating performance, disciplined deal-making, and strong returns on invested capital has reinforced perceptions of HEICO as a high-quality compounder in specialized aerospace and electronics markets. We’ll now examine how HEICO’s record profitability and strong cash...

Aveanna Healthcare Holdings (AVAH) raised its 2025 revenue guidance to a range of US$2.425b to US$2.445b and issued higher preliminary 2026 targets, putting its home based care model firmly in focus for investors. See our latest analysis for Aveanna Healthcare Holdings. Aveanna’s updated guidance comes after a mixed stretch in the market, with a 7 day share price return of 7.33% and a 90 day share price return of a 10.22% decline. Even so, the year to date share price return of 14.11% and a...

Landstar System recently announced that it released its fourth-quarter 2025 results on January 28, 2026, followed by a conference call with analysts and investors that same afternoon, with both live and replay access available through its investor relations website. Alongside this earnings communication, a broad group of research firms has reaffirmed coverage of Landstar while revisiting their expectations for the company’s longer-term business trajectory. We’ll explore how this cluster of...